( NYSE:ALR,NYSE:ALR.PRB )

News from Alere Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 21, 2017, 17:16 ET Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing

Alere Inc. (NYSE: ALR) (the "Company") announced today that, as a result of its failure to timely file its Annual Report on Form 10-K for...


Mar 20, 2017, 16:30 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...


Mar 09, 2017, 19:38 ET Alere Provides Update on Arriva Medical

Arriva Medical, a subsidiary of Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, in connection with Arriva Medical's complaint...


Mar 07, 2017, 07:00 ET Alere Receives FDA CLIA Waiver for Alere™ i RSV Rapid Molecular Test

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ i RSV test has been granted CLIA (Clinical Laboratory...


Jan 25, 2017, 11:00 ET European Commission Clears Abbott Acquisition of Alere

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced that the European Commission has granted clearance for Abbott Laboratories...


Jan 04, 2017, 20:26 ET Alere Provides Update on Arriva Medical

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today provided an update in connection with Arriva Medical's complaint filed on...


Jan 04, 2017, 07:00 ET Alere Laboratory Receives ABFT Accreditation

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its forensic toxicology division, Alere Forensics at Redwood...


Dec 28, 2016, 17:03 ET Alere Provides Update on Arriva Medical

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today provided an update on the decision by the Centers for Medicare &...


Dec 16, 2016, 16:15 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...


Dec 07, 2016, 12:59 ET Alere Issues Statement Regarding Abbott Lawsuit

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today issued the following statement in response to a lawsuit filed by Abbott...


Nov 14, 2016, 07:00 ET Alere Provides Additional Information Regarding Arriva Medical On Its Website

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has posted a fact sheet on its website providing...


Nov 04, 2016, 09:54 ET Alere Reports Third Quarter 2016 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported financial results...


Oct 21, 2016, 09:48 ET Alere Shareholders Approve Merger with Abbott

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced that its shareholders have voted to approve the...


Oct 20, 2016, 11:17 ET People's Republic of China Clears Abbott Acquisition of Alere

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics announced that it has received notification from the Ministry of Commerce of the...


Sep 14, 2016, 16:30 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...


Sep 06, 2016, 07:00 ET Alere Reports Second Quarter 2016 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported its financial...


Aug 26, 2016, 11:00 ET Alere Issues Statement

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today issued the following statement in response to inquiries...


Aug 19, 2016, 07:00 ET Alere Receives FDA Clearance for Alere™ i RSV Rapid Molecular Test

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ i RSV test has received 510(k) marketing...


Aug 17, 2016, 06:15 ET Alere Reports First Quarter 2016 Financial Results

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported its financial...


Aug 09, 2016, 07:00 ET Alere Achieves IVD CE Mark for its Alere™ Reader Lateral Flow Assay Analyzer

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced it has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for...


Aug 08, 2016, 06:22 ET Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial...


Aug 01, 2016, 16:15 ET Alere Opens New Diagnostics Manufacturing Facility in India

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the opening of a state-of-the-art diagnostics manufacturing...


Jul 27, 2016, 19:08 ET Alere Comments on Pain Management Subpoena

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it received a U.S. Department of Justice subpoena...


Jul 14, 2016, 17:17 ET Alere Inc. Announces Update on Form 10-K

 Alere Inc. (NYSE: ALR) (the "Company") announced today certain preliminary unaudited financial information for the fiscal year ended December...


Jul 13, 2016, 16:30 ET Alere™ HIV Combo Test Receives WHO Prequalification

Alere (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ HIV Combo, a rapid point-of-care fourth-generation...